Harnessing biological insight to accelerate tuberculosis drug discovery
Conspectus Tuberculosis (TB) is the leading cause of mortality globally resulting from an
infectious disease, killing almost 1.6 million people annually and accounting for …
infectious disease, killing almost 1.6 million people annually and accounting for …
Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
TJ de Wet, DF Warner, V Mizrahi - Accounts of Chemical Research, 2019 - europepmc.org
In the concluding section, we focus on the need for improved techniques to elucidate
mycobacterial metabolism during infection and its impact on disease outcomes. Here, we …
mycobacterial metabolism during infection and its impact on disease outcomes. Here, we …
[HTML][HTML] Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
TJ de Wet, DF Warner, V Mizrahi - Accounts of Chemical Research, 2019 - ncbi.nlm.nih.gov
In the concluding section, we focus on the need for improved techniques to elucidate
mycobacterial metabolism during infection and its impact on disease outcomes. Here, we …
mycobacterial metabolism during infection and its impact on disease outcomes. Here, we …
Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
TJ de Wet, DF Warner… - Accounts of chemical …, 2019 - pubmed.ncbi.nlm.nih.gov
Tuberculosis (TB) is the leading cause of mortality globally resulting from an infectious
disease, killing almost 1.6 million people annually and accounting for approximately 30% of …
disease, killing almost 1.6 million people annually and accounting for approximately 30% of …